A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock.
Using spontaneously beating rat myocardial cells as an in vitro model of myocardial depression, recent studies demonstrated that septic shock patients' sera frequently contain a myocardial depressant substance (MDS) that is associated with a reversible decrease in left ventricular ejection fraction (LVEF). To further characterize MDS, 50 consecutive patients with possible septic shock were studied serially from shock onset until recovery or death. Thirty-four patients had criteria diagnostic of septic shock, and 16 had a nonseptic critical illness. Of the 34, 14 met strict criteria for circulating MDS, with a mean inhibition of 35 percent (range 20 percent to 62 percent). Compared with those patients not exhibiting significant MDS activity, the 14 MDS-positive patients had a lower mean minimal EF (28 percent vs 39 percent, p less than 0.01), a greater mean decrease in EF (22.1 percent vs 8.8 percent, p = 0.002), a higher pulmonary artery wedge pressure (16.8 vs 11.9 mm Hg, p less than 0.01), greater LV dilatation (162 vs 118 ml/m2, p = 0.02), and a higher circulating mean peak lactic acid (6.9 vs 2.7 mmol/L, p less than 0.01). In the 14 MDS-positive patients, the in vitro myocardial cell depression had a negative correlation with the in vivo EF (r = -060, p less than 0.05). These findings suggest that a circulating MDS is a cause of the myocardial depression frequently accompanying human septic shock.
Reilly
J M
JM
Critical Care Medicine Department, National Institutes of Health, Bethesda 20892.
Cunnion
R E
RE
Burch-Whitman
C
C
Parker
M M
MM
Shelhamer
J H
JH
Parrillo
J E
JE
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001775:Blood Circulation; D002302:Cardiac Output; D002933:Cineradiography; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging / Q000503:physiopathology*; D006801:Humans; D007773:Lactates / Q000097:blood*; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction; D009201:Myocardial Depressant Factor / Q000097:blood*; D010455:Peptides / Q000097:blood*; D011446:Prospective Studies; D011875:Radionuclide Angiography; D051381:Rats; D012772:Shock, Septic / Q000097:blood*; D014655:Vascular Resistance
D007773:Lactates; D009201:Myocardial Depressant Factor; D010455:Peptides; D019344:Lactic Acid